Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYBiomedicines

Development and Preliminary Evaluation of a Pharmacogenetic Panel for Risk Stratification of Liver Injury in Polypharmacy

Related

  1. Development and Preliminary Psychometric Evaluation of a Questionnaire on Comprehensive Protection, Quality, and Humanization in Pediatric Hospital Care
    Germán Rojas Loyola, Begoña Polonio-López, Juan José Criado-Alvarez +1
    Pediatric reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Subjective word-finding complaints in older adults: Development and preliminary psychometric evaluation of a novel self-reported questionnaire
    F. El-Khaldi, A. Marier, P. Vitali +3
    medRxivPreprintAll rights reservedFull textPsychiatry & mental healthmedRxiv
  3. Development and Preliminary Evaluation of ASIApp for Breastfeeding Education: A Single-Group Pretest–Posttest Study in Makassar
    Asmi Asmi, Machmudah Machmudah, Sri Rejeki
    South East Asia Nursing ResearchPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  4. Development and preliminary psychometric evaluation of a spectacle trial-wear questionnaire for distance single-vision prescriptions.
    Meina Huang, Zheyi Chen
    Frontiers in medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Development and Preliminary Evaluation of a Brief Health Chatbot Acceptability Scale (CAS): A Pilot Study
    R. L. Ownby, J. Caballero, K. Thomas-Purcell
    medRxivPreprintCC BYFull textPsychiatry & mental healthmedRxiv
BibTeX
@article{anon2026development,
  title = {{Development and Preliminary Evaluation of a Pharmacogenetic Panel for Risk Stratification of Liver Injury in Polypharmacy}},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701328},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Development and Preliminary Evaluation of a Pharmacogenetic Panel for Risk Stratification of Liver Injury in Polypharmacy
PY  - 2026
DA  - 2026/09/24
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701328
SN  - 2227-9059
ER  -